Unfortunately, there are many challenges in HER2 testing and detection of HER2-low breast carcinoma, particularly when distinguishing between IHC scores of 0 and 1+ [6], as IHC companion diagnostic tests were optimized for the accurate detection of high HER2 protein expression levels [7]. The gene discussed is ERBB2; the disease is breast carcinoma.